gsk2251052
Showing 1 - 4 of 4
Infections, Urinary Tract Trial in Worldwide (GSK2251052, imipenem-cilastatin, Placebo)
Terminated
- Infections, Urinary Tract
- GSK2251052
- +2 more
-
Los Angeles, California
- +23 more
Aug 9, 2017
Community-acquired Infection Trial in Minneapolis (GSK2251052)
Completed
- Community-acquired Infection
- GSK2251052
-
Minneapolis, MinnesotaGSK Investigational Site
Jul 5, 2017
Community-acquired Infection Trial in Adelaide (GSK2251052)
Terminated
- Community-acquired Infection
- GSK2251052
-
Adelaide, South Australia, AustraliaGSK Investigational Site
Jun 27, 2017
Infections, Bacterial Trial in Adelaide (GSK2251052, Placebo)
Completed
- Infections, Bacterial
- GSK2251052
- Placebo
-
Adelaide, South Australia, AustraliaGSK Investigational Site
Jun 27, 2017